Home

Mark Schoenberg, Chief Medical Officer: UroGen Pharma URGN Sell · Filed 25/02/04

Trade details

Type
Insider sale
Amount
$21,121.44
Shares · price
1,896 sh · $11.14 a share
Held after
147,103 sh
Trade date
25/01/31
Filed
25/02/04
Days to filing
4 days

Sold 1.3% of holdings

Share of holding sold
1.3%

UroGen Pharma trades, last 26 weeks

What else happened in UroGen Pharma around then

Filed or reported within 30 days of the trade day · 25/01/01~25/03/02

Mark Schoenberg's recent trades

  • Mark Schoenberg

    Planned saleUroGen Pharma

    $38.4K

    Filed 09/09

  • Mark Schoenberg

    Planned saleUroGen Pharma

    $2.9M

    Filed 08/20

  • Mark Schoenberg

    Planned sale10b5-1 planUroGen Pharma

    $400K

    Filed 07/09

  • Mark Schoenberg

    Sell10b5-1 planUroGen Pharma

    $350.1K

    Filed 06/24

  • Mark Schoenberg

    Planned sale10b5-1 planUroGen Pharma

    $350.1K

    Filed 06/22

Mark Schoenberg, Chief Officer — sold $21.1K of UroGen Pharma URGN · 1.3% of holdings | Whalegun